HOME >> BIOLOGY >> NEWS
UPCI Researchers Find Drug Improves Cancer-Fighting Ability Of Vitamin D

PITTSBURGH, Jan. 20 -- A steroid drug enhances the ability of a vitamin D analogue to kill cancer while reducing a potentially serious side effect of vitamin D therapy, according to investigators at the University of Pittsburgh Cancer Institute (UPCI). Their findings on dexamethasone and the vitamin D derivative, 1,25-dihydroxyvitamin-D3, (1,25-D3), in an animal model are reported in the Jan. 21 issue of the Journal of the National Cancer Institute.

"We were very excited to find that not only did dexamethasone reduce hypercalcemia associated with 1,25-D3 , it actually improved the ability of 1,25-D3 to kill cancer cells in an animal model," noted Candace Johnson, Ph.D., study investigator, interim director for basic research at UPCI and co-director of UPCI's Molecular Oncology/Drug Discovery Program.

"We have previously shown that 1,25-D3 effectively halts the growth of cancer in animals, and we have conducted preliminary trials of this agent in men with advanced prostate and other cancers. However, the use of 1,25-D3 has been limited because this drug causes a potentially life-threatening increase of calcium in the blood," said Donald Trump, M.D., an investigator on the study, deputy director for clinical investigations at UPCI and director of the UPMC Health System's division of medical oncology.

UPCI investigators were among the first to describe the anti-tumor activity of vitamin-D compounds, or analogues, and showed that they arrest cancer growth in culture and in animals. While other researchers had previously shown the effect of vitamin D analogues in leukemia cells, Dr. Johnson and Dr.Trump were among the first to demonstrate the efficacy of these agents against solid tumors such as prostate cancer and head and neck cancers. Currently, the UPCI team is conducting a clinical protocol combining a steroid with 1,25-D3 for advanced cancer.

Dexamethasone appears to enhance 1,25
'"/>

Contact: Lauren Ward
wardla@a1.isd.upmc.edu
(412) 624-2607
University of Pittsburgh Medical Center
20-Jan-1998


Page: 1 2

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers identify protein promoting vascular tumor growth
4. Researchers devise potent new tools to curb ivory poaching
5. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
6. Researchers ID chlorophyll-regulating gene
7. Researchers develop fast track way to discover how cells are regulated
8. Researchers identify distinctive signature for metastatic prostate cancer
9. Researchers report new gene test for isolated cleft lip and palate
10. Researchers discover why mutant gene causes colon cancer
11. Researchers identify the genomes controlling elements

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2020)... ... ... The field of quantitation of large molecules or proteins has been around for ... use of mass spectrometry in this field has gained a lot of momentum in ... which approach to use (LBA or MS)?” In many cases, either technology can ...
(Date:6/23/2020)... ... , ... In its June 22 online post, business and technology news platform ... Ph.D., founder and director of stem cell biotechnology company Asymmetrex . Superb Crew ... starting July 5 it would begin offering free tissue stem cell counting ...
(Date:6/19/2020)... ... June 18, 2020 , ... ... Lab with Software for Data Decisions,” for pharmaceutical and biotech executives, laboratory ... and automate cutting-edge scientific instruments and laboratory equipment from dozens of manufacturers ...
Breaking Biology News(10 mins):
(Date:6/23/2020)... ... June 22, 2020 , ... Regen ... special offer. This includes buy three, get the fourth unit free with no ... Amniotic derived exosomes, known as exosomes, have been a game changer for regenerative ...
(Date:6/23/2020)... ... June 23, 2020 , ... Nobilis Therapeutics, ... that it has filed an Investigational New Drug application (IND) with the U.S. ... its lead drug candidate NBTX-001 in patients with panic disorder (PD). , "Adding ...
(Date:6/11/2020)... ... June 08, 2020 , ... Greffex, a ... the use of proprietary clean viral vectors, recently announced a key manufacturing agreement ... Greffex’s platform is the world’s most successful gene therapy delivery vehicle (vector) with ...
(Date:6/11/2020)... ... June 09, 2020 , ... TRX ... NEON Micro-Tracer Solution, a highly accurate, contact tracing solution for identification ... workplace. Contact tracing, a core disease control measure, is a key strategy for ...
Breaking Biology Technology:
Cached News: